Načítá se...
One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology
OBJECTIVE: The aim was to study the effect of non-mandatory transitioning from etanercept originator to etanercept biosimilar on retention rates in a setting promoting shared decision-making. METHODS: In 2016, all patients treated with etanercept originator and stable disease at the Rheumatology dep...
Uloženo v:
| Vydáno v: | Rheumatol Adv Pract |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519774/ https://ncbi.nlm.nih.gov/pubmed/33005860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa042 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|